Pain / The Purdue Frederick Company / Symptom Management / Immediate Release Cytogel Pharma LLC. / Purdue Pharma / Cytogel Pharma / Cytogel Pharma Cytogel Pharma LLC. / /
Event
FDA Phase / /
Facility
National Cancer Institute / Sloan-Kettering Institute / University of Connecticut School / /
IndustryTerm
biopharmaceutical development / /
MedicalCondition
MS / /
Organization
National Cancer Institute / Drug Abuse Advisory Board / World Health Organization / Eastern Pain Association / Veteran’s Administration / Food and Drug Administration / Sloan-Kettering Institute for Cancer Research / Cornell University Graduate School / Federal Trade Commission / University of Connecticut School of Pharmacy / Department of Pharmacology / /
Person
Robert F. Kaiko / Dean Maglaris / Robert Kaiko / /
Position
instructor and adjunct assistant professor / CEO / scientific and clinical advisor / contributing editor / associate medical director / vice president of clinical research and vice president / R&D portfolio development / contributing editor for the Journal / president and board member / research associate / board member / /
To be Submitted for Immediate Release Cytogel Pharma, LLC. announces Dr. Robert Kaiko as scientific and clinical advisor to help plan and implement its clinical development program for Cyt1010. Date: 26-March-2014 DARIE